The generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated
that adult mammalian cells can be reprogrammed to a pluripotent state by the enforced …

The ability to generate induced pluripotent stem cells (iPSCs) from patients, and an
increasingly refined capacity to differentiate these iPSCs into disease-relevant cell types …

Human induced pluripotent stem cells (iPSCs) have been generated with varied efficiencies
from multiple tissues. Yet, acquiring donor cells is, in most instances, an invasive procedure …

Generation of induced pluripotent stem (iPS) cells holds a great promise for regenerative
medicine and other aspects of clinical applications. Many types of cells have been …

Generation of induced pluripotent stem cells (iPSCs) has opened new avenues for the
investigation of heart diseases, drug screening and potential autologous cardiac …

We have developed a renewable, scalable and transgene free human blood-brain barrier
model, composed of brain endothelial cells (BECs), generated from human amniotic fluid …

The umbilical cord and placenta are extra-embryonic tissues of particular interest for
regenerative medicine. They share an early developmental origin and are a source of vast …

Cardiovascular progenitor cells (CVPCs) derived from human pluripotent stem cells
(hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent …

Foetal stem cells (FSCs) can be isolated during gestation from many different tissues such
as blood, liver and bone marrow as well as from a variety of extraembryonic tissues such as …

Induced pluripotent stem cells (iPSCs) with potential for therapeutic applications can be
derived from somatic cells via ectopic expression of a set of limited and defined transcription …